Niedzwiedz, C. L. , Robb, K. A. , Katikireddi, S. V. , Pell, J. P. and Smith, D. J. (2020) Depressive symptoms, neuroticism and participation in breast and cervical cancer screening: cross-sectional and prospective evidence from UK Biobank. Psycho-Oncology, 29(2), pp. 381-388. (doi: 10.1002/pon.5272) (PMID:31663185) (PMCID:PMC7002161)
|
Text
201396.pdf - Published Version Available under License Creative Commons Attribution. 1MB |
Abstract
Objective: To assess the cross‐sectional and prospective associations between depressive symptoms, neuroticism, and participation in breast and cervical screening in the UK. Methods: Women in the UK Biobank cohort with complete data who were eligible for breast cancer screening (aged 50‐70 years, N = 143 461) and/or cervical screening (<65 years, N = 141 753) at baseline recruitment (2006‐2010) and those with follow‐up data (2014‐2019) were identified (N = 11 050 and N = 9780 for breast and cervical screening). Depressive symptoms and neuroticism were self‐reported at baseline (range 0‐12 with higher scores reflecting greater severity). Primary outcomes were reporting being up to date with breast and cervical screening. For prospective analyses, patterns of screening participation from baseline to follow‐up were identified. Logistic regression was used to analyse associations, adjusted for potential confounding factors. Results: More severe depressive symptoms were associated with reduced likelihood of breast (OR = 0.960, 95% CI: 0.950,0.970) and cervical (OR = 0.958, 95% CI: 0.950,0.966) screening participation, in cross‐sectional analyses. Higher neuroticism scores were associated with reduced cervical screening participation, but the opposite was found for breast cancer screening. Examination of individual neuroticism items revealed that anxiety and worry were associated with increased breast screening. At follow‐up, higher baseline depressive symptoms were related to decreased cervical screening (OR = 0.955, 95% CI: 0.913,0.999), but not with breast screening. Conclusions: More severe depressive symptoms may be a barrier for breast and cervical screening and could be an indicator for more proactive strategies to improve uptake.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Katikireddi, Professor Vittal and Pell, Professor Jill and Smith, Professor Daniel and Niedzwiedz, Dr Claire and Robb, Professor Katie |
| Authors: | Niedzwiedz, C. L., Robb, K. A., Katikireddi, S. V., Pell, J. P., and Smith, D. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Mental Health and Wellbeing College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > MRC/CSO SPHSU |
| Journal Name: | Psycho-Oncology |
| Publisher: | Wiley |
| ISSN: | 1057-9249 |
| ISSN (Online): | 1099-1611 |
| Published Online: | 30 October 2019 |
| Copyright Holders: | Copyright © 2019 The Authors |
| First Published: | First published in Psycho-Oncology 29(2):381-388 |
| Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information